CA2862483A1 - Sandalwood oil and its uses related to clostridium infections - Google Patents
Sandalwood oil and its uses related to clostridium infections Download PDFInfo
- Publication number
- CA2862483A1 CA2862483A1 CA2862483A CA2862483A CA2862483A1 CA 2862483 A1 CA2862483 A1 CA 2862483A1 CA 2862483 A CA2862483 A CA 2862483A CA 2862483 A CA2862483 A CA 2862483A CA 2862483 A1 CA2862483 A1 CA 2862483A1
- Authority
- CA
- Canada
- Prior art keywords
- infection
- subject
- clostridium
- sandalwood oil
- oil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N65/00—Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
- A01N65/08—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Dentistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Agronomy & Crop Science (AREA)
- Plant Pathology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261589601P | 2012-01-23 | 2012-01-23 | |
| US61/589,601 | 2012-01-23 | ||
| PCT/US2013/022743 WO2013112582A1 (en) | 2012-01-23 | 2013-01-23 | Sandalwood oil and its uses related to clostridium infections |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2862483A1 true CA2862483A1 (en) | 2013-08-01 |
Family
ID=48873861
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2862483A Abandoned CA2862483A1 (en) | 2012-01-23 | 2013-01-23 | Sandalwood oil and its uses related to clostridium infections |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US9579354B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2806882B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP6134739B2 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2013212264B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2862483A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2013112582A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20140154342A1 (en) * | 2011-07-28 | 2014-06-05 | Santalis Pharmaceuticals Inc. | Sandalwood oil and its uses related to skin disorders |
| WO2014160279A1 (en) | 2013-03-13 | 2014-10-02 | Viroxis Corporation | Stabilized cream formulations comprising sandalwood oil |
| JP2018529752A (ja) | 2015-10-07 | 2018-10-11 | サンタリス ファーマシューティカルズ インコーポレイテッド | サンダルウッド油及び口腔粘膜炎に関連するその用途 |
| WO2018165108A1 (en) | 2017-03-08 | 2018-09-13 | Hope Medical Enterprises, Inc. Dba Hope Pharmaceuticals | Intradialytic use of sodium thiosulfate |
| KR102647803B1 (ko) | 2017-03-08 | 2024-03-15 | 호프 메디칼 엔터프라이즈스, 인크, 디비에이, 호프파마수으티칼즈 | 아질산나트륨의 투석중 용도 |
| CA3109900A1 (en) * | 2018-08-17 | 2020-02-20 | Universidad Andres Bello | Method and pharmacological composition for the prevention of recurrent infections caused by clostridium difficile |
| CN111544353A (zh) * | 2020-05-21 | 2020-08-18 | 天津芸熙生物技术有限公司 | 一种抑菌口腔喷雾剂及其制备方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996007430A1 (en) | 1994-09-06 | 1996-03-14 | Galagen, Inc. | Therapeutic treatment of clostridium difficile associated diseases |
| GB0414886D0 (en) | 2004-07-02 | 2004-08-04 | Neutec Pharma Plc | Treatment of bacterial infections |
| JP2006124296A (ja) * | 2004-10-27 | 2006-05-18 | Tomihiko Higuchi | ヘリコバクター・ピロリ菌感染症治療のための医薬組成物 |
| US7858126B2 (en) * | 2006-08-31 | 2010-12-28 | Trinity Laboratories Inc. | Derivatives of sandalwood oil and santalols for treating cold sores and herpes |
| WO2009014781A2 (en) * | 2007-05-02 | 2009-01-29 | Nucryst Pharmaceuticals Corp. | Metal-containing materials for treatment of bacterial conditions |
| KR101842289B1 (ko) * | 2010-03-01 | 2018-03-26 | 산탈리스 파마슈티컬스, 인크. | 백단유 및 이의 용도 |
| AU2011239470B2 (en) | 2010-04-15 | 2015-09-10 | Progenics Pharmaceuticals, Inc. | Antibodies for the treatment of Clostridium difficile-associated infection and disease |
| WO2011146624A2 (en) * | 2010-05-18 | 2011-11-24 | Optimer Pharmaceuticals, Inc. | Methods of treating recurring bacterial infection |
| US20130224164A1 (en) * | 2010-09-10 | 2013-08-29 | Viropharma Incorporated | Environmental Clostridial Bacteriotherapy and Related Formulations and Methods of Manufacture and Use |
-
2013
- 2013-01-23 CA CA2862483A patent/CA2862483A1/en not_active Abandoned
- 2013-01-23 WO PCT/US2013/022743 patent/WO2013112582A1/en not_active Ceased
- 2013-01-23 AU AU2013212264A patent/AU2013212264B2/en not_active Ceased
- 2013-01-23 EP EP13741240.9A patent/EP2806882B1/en not_active Not-in-force
- 2013-01-23 US US14/373,810 patent/US9579354B2/en not_active Expired - Fee Related
- 2013-01-23 JP JP2014553530A patent/JP6134739B2/ja not_active Expired - Fee Related
-
2017
- 2017-01-13 US US15/405,921 patent/US10322154B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US20150238551A1 (en) | 2015-08-27 |
| EP2806882A1 (en) | 2014-12-03 |
| JP2015505540A (ja) | 2015-02-23 |
| EP2806882A4 (en) | 2015-08-05 |
| AU2013212264B2 (en) | 2017-05-18 |
| US10322154B2 (en) | 2019-06-18 |
| US20170128509A1 (en) | 2017-05-11 |
| EP2806882B1 (en) | 2018-11-14 |
| US9579354B2 (en) | 2017-02-28 |
| JP6134739B2 (ja) | 2017-05-24 |
| AU2013212264A1 (en) | 2014-08-07 |
| WO2013112582A1 (en) | 2013-08-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10322154B2 (en) | Sandalwood oil and its uses related to clostridium infections | |
| Tactacan et al. | A Bacillus subtilis (QST 713) spore-based probiotic for necrotic enteritis control in broiler chickens | |
| US20130136695A1 (en) | Methods and compositions including spore-forming bacteria for increasing the health of animals | |
| EP3444330B1 (en) | Strain of genus agathobaculum having effects of preventing or treating degenerative brain diseases, and use thereof | |
| AU2019229354B2 (en) | Volatile organic compound formulations having antimicrobial activity | |
| Heres et al. | Effect of fermented feed on the susceptibility for Campylobacter jejuni colonisation in broiler chickens with and without concurrent inoculation of Salmonella enteritidis | |
| US20180028490A1 (en) | Methods Of Treating Diarrhea And Promoting Intestinal Health In Non-Human Animals | |
| KR20210004221A (ko) | 알파-망고스틴, 감마-망고스틴 또는 셀라스트롤을 포함하는 항균활성을 가진 조성물 | |
| KR20210053637A (ko) | 케피어 유래 프로바이오틱 효모 클루이베로미세스 막시아누스 a5 및 이의 용도 | |
| Moore et al. | The effect of an experimental chlorate product on Salmonella recovery of turkeys when administered prior to feed and water withdrawal | |
| KR20090078065A (ko) | 항균효과가 강화된 사료첨가용 유산균제제 와 그 제조방법 | |
| CA3117821A1 (en) | Volatile organic compound formulations having antimicrobial activity | |
| US12097173B2 (en) | Volatile organic compound formulations having antimicrobial activity | |
| KR102208837B1 (ko) | 메틸 갈레이트 및 플로로퀴놀론 계열 항균제를 포함하는 박테리아의 장 부착, 침입 억제, 또는 항생제 내성 억제용 조성물 | |
| EA043409B1 (ru) | Ветеринарное пробиотическое средство | |
| HK40025284A (en) | Volatile organic compound formulations having antimicrobial activity | |
| CN105998312A (zh) | 治疗鸡禽沙门氏菌病的中药组合物及鸡饲料 | |
| RU2802308C2 (ru) | Композиции летучих органических веществ, обладающие антимикробной активностью | |
| Kantas et al. | A feed additive containing Bacillus toyonensis in weaning piglets | |
| NZ715859B2 (en) | Volatile organic compound formulations having antimicrobial activity | |
| JP2010126472A (ja) | クロストリジウム症の予防及び/又は治療用飼料 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20171123 |
|
| FZDE | Discontinued |
Effective date: 20200831 |